
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65Â years of age and older: A phase II, observer-blind, randomized, controlled trial
Keywords: H7N1; H7N9; Pandemic flu; H7 influenza vaccine; AS03 adjuvant; Elderly population; AE; adverse event; CI; confidence interval; GMT; geometric mean titers; HA; hemagglutinin; HI; hemagglutination inhibition; MGI; mean geometric increase; MN; microneutraliz